Open AccessAssessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
Author(s) -
Rayan Hamza Mohammed Ahmedalgabri,
Tarig Omer,
Fatima Zarroug,
Abdullah Omer Elkhawad,
Mounkaïla Noma
Publication year - 2022
Publication title -
clinical pharmacology
Language(s) - English
Resource type - Journals
ISSN - 1179-1438
DOI - 10.2147/cpaa.s338926
Subject(s) - diabetic macular edema , medicine , optometry , ophthalmology , center (category theory) , diabetes mellitus , diabetic retinopathy , endocrinology , chemistry , crystallography
Anti-vascular endothelial growth factor (anti-VEGF) medicines have revolutionized DME and DR treatment. Despite the worldwide use of anti-VEGFs, their use remains limited in Sudan. This study aimed to assess the impact of anti-VEGF (ranibizumab and bevacizumab) injections in patients with diabetic macular oedema in Khartoum, Sudan.